Faruqi & Faruqi, LLP Announces the Investigation of BioMed Realty Trust, Inc. (BMR) Over the Proposed Sale of the Company to Blackstone
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BioMed Realty Trust, Inc. (“BioMed” or the “Company”) (NYSE:BMR) for potential breaches of fiduciary duties in connection with the sale of the Company to Blackstone for approximately $8 billion in a cash transaction, including debt.
The Company’s stockholders will only receive $23.75 for each share of BioMed common stock they own. However, the offer is inadequate since BioMed shares have traded as high as $25.11 as recently as January.
If you own common stock in BioMed and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.